217 related articles for article (PubMed ID: 34238470)
1. Prader-Willi syndrome: Hormone therapies.
Tauber M; Diene G
Handb Clin Neurol; 2021; 181():351-367. PubMed ID: 34238470
[TBL] [Abstract][Full Text] [Related]
2. Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction.
Tauber M; Hoybye C
Lancet Diabetes Endocrinol; 2021 Apr; 9(4):235-246. PubMed ID: 33647242
[TBL] [Abstract][Full Text] [Related]
3. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
4. Peptides associated with hyperphagia in adults with Prader-Willi syndrome before and during GH treatment.
Höybye C; Barkeling B; Espelund U; Petersson M; Thorén M
Growth Horm IGF Res; 2003 Dec; 13(6):322-7. PubMed ID: 14624765
[TBL] [Abstract][Full Text] [Related]
5. Disentangling ingestive behavior-related phenotypes in Prader-Willi syndrome: Integrating information from nonclinical studies and clinical trials to better understand the pathophysiology of hyperphagia and obesity.
Wevrick R
Physiol Behav; 2020 May; 219():112864. PubMed ID: 32156555
[TBL] [Abstract][Full Text] [Related]
6. Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
Oztan O; Zyga O; Stafford DEJ; Parker KJ
Neurosci Biobehav Rev; 2022 Nov; 142():104870. PubMed ID: 36113782
[TBL] [Abstract][Full Text] [Related]
7. Advances in genetic mechanisms of hypothalamic dysfunction in Prader-Willi syndrome.
Wang XY; Sun R; Gao YQ
Yi Chuan; 2022 Oct; 44(10):899-912. PubMed ID: 36384726
[TBL] [Abstract][Full Text] [Related]
8. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
9. Clinical Trials in Prader-Willi Syndrome: A Review.
Mahmoud R; Kimonis V; Butler MG
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768472
[TBL] [Abstract][Full Text] [Related]
10. Hormonal, metabolic and skeletal phenotype of Schaaf-Yang syndrome: a comparison to Prader-Willi syndrome.
McCarthy JM; McCann-Crosby BM; Rech ME; Yin J; Chen CA; Ali MA; Nguyen HN; Miller JL; Schaaf CP
J Med Genet; 2018 May; 55(5):307-315. PubMed ID: 29496979
[TBL] [Abstract][Full Text] [Related]
11. Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.
Correa-da-Silva F; Fliers E; Swaab DF; Yi CX
J Neuroendocrinol; 2021 Jul; 33(7):e12994. PubMed ID: 34156126
[TBL] [Abstract][Full Text] [Related]
12. Prader-Willi Syndrome: Clinical Genetics and Diagnostic Aspects with Treatment Approaches.
Butler MG; Manzardo AM; Forster JL
Curr Pediatr Rev; 2016; 12(2):136-66. PubMed ID: 26592417
[TBL] [Abstract][Full Text] [Related]
13. A boy with Prader-Willi syndrome: unmasking precocious puberty during growth hormone replacement therapy.
Ludwig NG; Radaeli RF; Silva MM; Romero CM; Carrilho AJ; Bessa D; Macedo DB; Oliveira ML; Latronico AC; Mazzuco TL
Arch Endocrinol Metab; 2016; 60(6):596-600. PubMed ID: 27982202
[TBL] [Abstract][Full Text] [Related]
14. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings.
Angulo MA; Butler MG; Cataletto ME
J Endocrinol Invest; 2015 Dec; 38(12):1249-63. PubMed ID: 26062517
[TBL] [Abstract][Full Text] [Related]
15. Prader-Willi syndrome: advances in genetics, pathophysiology and treatment.
Goldstone AP
Trends Endocrinol Metab; 2004; 15(1):12-20. PubMed ID: 14693421
[TBL] [Abstract][Full Text] [Related]
16. Approach to the Patient With Prader-Willi Syndrome.
Höybye C; Tauber M
J Clin Endocrinol Metab; 2022 May; 107(6):1698-1705. PubMed ID: 35150573
[TBL] [Abstract][Full Text] [Related]
17. Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.
Griggs JL; Sinnayah P; Mathai ML
Neurosci Biobehav Rev; 2015 Dec; 59():155-72. PubMed ID: 26475993
[TBL] [Abstract][Full Text] [Related]
18. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review.
Tan Q; Orsso CE; Deehan EC; Triador L; Field CJ; Tun HM; Han JC; Müller TD; Haqq AM
Obes Rev; 2020 May; 21(5):e12992. PubMed ID: 31889409
[TBL] [Abstract][Full Text] [Related]
19. Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation.
Madeo SF; Zagaroli L; Vandelli S; Calcaterra V; Crinò A; De Sanctis L; Faienza MF; Fintini D; Guazzarotti L; Licenziati MR; Mozzillo E; Pajno R; Scarano E; Street ME; Wasniewska M; Bocchini S; Bucolo C; Buganza R; Chiarito M; Corica D; Di Candia F; Francavilla R; Fratangeli N; Improda N; Morabito LA; Mozzato C; Rossi V; Schiavariello C; Farello G; Iughetti L; Salpietro V; Salvatoni A; Giordano M; Grugni G; Delvecchio M
Front Endocrinol (Lausanne); 2024; 15():1382583. PubMed ID: 38737552
[TBL] [Abstract][Full Text] [Related]
20. Prader-Willi syndrome: A model for understanding the ghrelin system.
Tauber M; Coupaye M; Diene G; Molinas C; Valette M; Beauloye V
J Neuroendocrinol; 2019 Jul; 31(7):e12728. PubMed ID: 31046160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
